HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| 381.0% | 509.4% | 1,171.4% | 184.2% | 304.3% | 400.0% | 868.8% | 315.7% | 127.4% | 125.7% | 225.1% | 619.6% | 164.3% | 529.8% | 115.6% | 599.9% | 472.2% | 427.0% | 78.7% | 6.6% | 240.3% | – | 3.9% | 8.5% | – | 22.3% | 6.2% | 5.8% | |
| -281.0% | -409.4% | -1,071.4% | -84.2% | -204.3% | -300.0% | -768.8% | -215.7% | -27.4% | -25.7% | -125.1% | -519.6% | -64.3% | -429.8% | -15.6% | -499.9% | -372.2% | -327.0% | 21.3% | 93.4% | 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | 0.0% | – | – | |
| – | 59.4% | 164.3% | 19.2% | 50.0% | 73.8% | 165.6% | 57.3% | 23.9% | 25.0% | 40.7% | 128.3% | 34.6% | 201.8% | 159.8% | 713.4% | 529.5% | 457.0% | 83.1% | 1.4% | 281.6% | – | 0.6% | 1.3% | – | 3.8% | 1.5% | 0.9% | |
| 69.0% | 71.9% | 171.4% | 25.4% | 62.8% | 83.6% | 190.6% | 74.2% | 30.9% | 33.7% | 49.1% | 165.2% | 43.4% | 236.8% | 3,520.0% | 16,280.1% | 10,081.2% | 2,962.1% | 212.2% | 1.8% | 281.6% | – | 0.8% | 1.8% | – | 5.0% | 1.6% | 0.9% | |
| -350.0% | -478.1% | -1,250.0% | -109.6% | -268.1% | -383.6% | -959.4% | -291.0% | -58.3% | -59.4% | -174.9% | -684.8% | -107.7% | -666.7% | -59.8% | -613.4% | -429.5% | -357.0% | -60.3% | -5.6% | -181.6% | – | 99.2% | 98.2% | – | 95.0% | 98.4% | 99.1% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 3,679.6% | 16,994.4% | 10,610.3% | 3,419.1% | 129.1% | 103.8% | 1,625.1% | – | 0.0% | 0.0% | – | – | – | – | |
| 5,192.9% | 4,746.9% | -21,700.0% | -5,368.9% | -5,362.8% | 6,331.1% | 2,237.5% | 5,029.2% | -932.2% | 1,753.8% | 3,607.8% | -4,710.9% | 559.9% | 6,573.7% | 3,620.0% | 16,380.1% | 10,181.2% | 3,062.1% | -189.3% | 98.2% | 1,443.4% | – | 99.2% | 98.2% | – | 95.0% | 98.4% | 99.1% | |
| – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | – | – | – | 3,679.8% | 16,993.5% | 10,610.7% | 3,419.1% | 418.3% | 0.0% | 0.0% | – | -1.7% | -6.3% | – | 95.0% | – | – | |
| 5,192.9% | 4,746.9% | -21,700.0% | -5,368.9% | -5,362.8% | 6,331.1% | 2,237.5% | 5,029.2% | -932.2% | 1,753.8% | 3,607.8% | -4,710.9% | 559.9% | 6,573.7% | 3,620.0% | 16,380.1% | 10,181.2% | 3,062.1% | -189.3% | 98.2% | 1,443.4% | – | 99.2% | 98.2% | – | 95.0% | 98.4% | 99.1% | |
| 5,192.9% | 4,746.9% | -1,250.0% | -109.6% | -268.1% | 6,331.1% | 2,237.5% | 5,029.2% | -58.3% | 1,753.8% | 3,607.8% | -684.8% | 559.9% | 6,573.7% | 3,679.8% | 33,375.4% | 20,791.8% | 6,481.2% | -318.4% | 98.2% | 3,068.5% | – | 99.2% | 98.2% | – | 95.0% | 100.6% | 99.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.